期刊文献+

sCD40L在多种疾病及输血不良反应的作用 被引量:1

下载PDF
导出
摘要 血小板在制备、储存过程中会发生活化,通常CD40配体(CD40L)在静息血小板里,会通过跨膜的方式从活化的血小板膜内侧转移到膜外侧上,释放到外环境(血浆),成为可溶性CD40L(sCD40L)。CD40是sCD40L的受体,其在多种细胞中表达,两者结合可诱导诱导炎症反应发生。在多种疾病状态下,如心肌损伤、中风、高胆固醇及其他心血管疾病,sCD40L的血浆浓度升高;且许多研究已发现sCD40L与输血不良反应具有相关性。因此了解sCD40L生物学特性,对识别患者发生输血不良反应的危险性具有重要作用,从而将可能为预防不良反应的发生奠定基础。
出处 《中国输血杂志》 CAS CSCD 北大核心 2013年第9期934-935,共2页 Chinese Journal of Blood Transfusion
  • 相关文献

参考文献19

  • 1Rizvi M,Pathak D, Freedman JE,et al.. CD40-CD40 ligand inter- actions in oxidative stress, inflammation and vascular disease. Trends Mol Med, 2008 ; 14:530-538.
  • 2Andre P, Nannizzi-Alaimo L, Prasad SK, et al. Platelet-derived CD40L: the switch-hitting player of cardiovascular disease. Circla- tion, 2002,106 : 896 -899.
  • 3Sahler J,Spinelli S,Phipps R,et al. CD40 ligand (CD154) in- volvement in platelet transfusion reactions. Transfus Clin et Bi- ol 2012,19(3) :98-103.
  • 4Tanaka S, Hayashi T,Tani Y ,et al. Removal by adsorbent beads of biological response modifiers released from platelets, accumulated during storage,and potentially associated with platelet transfusion reactions. Transfusion,2010,50 ( 5 ) : 1096- 1105.
  • 5Henn V,Slupsky JR,Gr? fe M, ,et al. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Na- ture, 1998,391:591-594.
  • 6Hollenbaugh D, Mischel-Petty N, Edwards CP, et al. Expressiou of functional CD40 by vascalar endothelial cells. J Exp Med, 1995, 182(1) : 33-40.
  • 7Kaufman J,Spinelli SL,Schultz E,et al. Release of biologically ac- tive CD154 during collection and storage of platclet concentrates prepared for transfusion. J Thromb Haemost ,2007,5:788-796.
  • 8SchaferA and Bauersacbs J. Endothelial dysfunction, impaired en- dogenous platelet inhibition and platelet activation in diabetes and atherosclerosis. Curr Vasc Pharmacol,2008,6( 1 ) , : 52-60.
  • 9Doran AC , Meller N, McNamara CA. The role of smooth muscle cells in the initiation and early progression of atherosclerosis. Arte- rioscler Thromb Vasc Biol,2008,28 (5), : 812-819.
  • 10Watanabe M, Sanqawa A, Sasaki Y. Distribution of inflammatory cells in adventitia changed with advancing atherosclerosis of human coronary artery. J. Atheroscler Thromb,2007 ; ,14: 325-331.

同被引文献10

  • 1Mazzezi CA, Popovsky MA, Kopko PM. American Association of Blood Banks. 16th ed. Maryland: 2008. Noninfectious complica- tions of blood transfusion. In Technical manual; pp. 5-51.
  • 2Gruji6 J, Gulan Z, Budakov Z. Importance of haemovigilance and reports on transfusion reaction in bJood component therapy. Med Pregl,2012,65(1-2) :50-53.
  • 3Payandeh M,Zare ME, Kansestani AN , et al. Descriptions of A- cute Transfusion Reactions in the Teaching Hospitals of Kerman- shah University of Medical Sciences, Iran,2013, 7(2) :11-16.
  • 4CaUera F, Silva CO, Moura AF ,et al. Description of acute trans- fusion reactuions in a Brazilian transfusion service. Bras Hematal Hemoter,2004,26 (2) :78-83.
  • 5Kumar R, Gupta M,Gupta V, et al. Acute Transfusion Reactions (ATRs) in Intensive Care Unit (ICU): A Retrospective Study. 2014, 8(2) :127-129.
  • 6Heddle NM, Klama LN, Griffith L ,et al. A prospective study to i- dentify the risk factors associated with acute reactions to platelet and red cell transfusions. Transfusion,1993,33:794-797.
  • 7Khalid S, Usman M, Mohammad K. Acute transfusion reactions encguntered in patients at a tertiary care center. J Pak Med Assoc, 2010 ;60(10) :832-836.
  • 8Netzer G, Dutton RP, Hess JR. Blood transfusion in critical care.F1000 Med Rep,2009,1.
  • 9Lavoie J. Blood transfusion risks and ahemative strategies in pedi- atric patients. Paediatr Anaesth ,2011,21 ( 1 ) : 14-24.
  • 10Sokolovic M, Pastores SM. Transfusion therapy and acute lung inju- ry. Expert Rev Respir Med,2010,4(3) :387-393.

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部